By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – EMD Millipore today announced that it has signed an agreement to acquire Seattle-based Amnis, a developer and manufacturer of high-speed cellular imaging instruments.

Amnis' technology is used for flow cytometry applications in academic, biotech, and pharmaceutical cell analysis and research. The acquisition complements EMD Millipore's existing Guava product offerings.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.